Exhibit 10.36

EXECUTION VERSION

JOINDER AGREEMENT

This Joinder Agreement is dated as of February 6, 2014 (this “Agreement”), by
and among each of the financial institutions set forth on Schedule A annexed
hereto (each a “New Term Loan Lender” and collectively the “New Term Loan
Lenders”), Valeant Pharmaceuticals International, Inc., a corporation continued
under the laws of the Province of British Columbia (“Borrower”), the undersigned
subsidiaries of Borrower and Goldman Sachs Lending Partners LLC (“GSLP”), as
Administrative Agent and Collateral Agent.

RECITALS:

WHEREAS, reference is hereby made to the Third Amended and Restated Credit and
Guaranty Agreement, dated as of February 13, 2012, as amended by Amendment
No. 1, dated as of March 6, 2012, by Amendment No. 2, dated as of September 10,
2012, by Amendment No. 3, dated as of January 24, 2013, by Amendment No. 4,
dated as of February 21, 2013, by Amendment No. 5, dated as of June 6, 2013, by
Amendment No. 6, dated as of June 26, 2013, by Amendment No. 7, dated as of
September 17, 2013, by Amendment No. 8, dated as of December 20, 2013
(“Amendment No. 8”), as further supplemented by the Joinder Agreement, dated as
of June 14, 2012, by the Joinder Agreement, dated as of July 9, 2012, by the
Joinder Agreement, dated as of September 11, 2012, by the Joinder Agreement
dated as of October 2, 2012, by the Joinder Agreement, dated as of December 11,
2012 and by the Joinder Agreements, each dated as of August 5, 2013 (as it may
be amended, restated, replaced, supplemented or otherwise modified from time to
time, the “Credit Agreement”; the terms defined therein and not otherwise
defined herein being used herein as therein defined), among Borrower, certain
Subsidiaries of Borrower, as Guarantors, the Lenders party thereto from time to
time, GSLP, J.P. Morgan Securities LLC and Morgan Stanley Senior Funding, Inc.
(“Morgan Stanley”), as Joint Lead Arrangers and Joint Bookrunners, JPMorgan
Chase Bank, N.A. (“JPMorgan”) and Morgan Stanley, as Co-Syndication Agents,
JPMorgan, as Issuing Bank, GSLP, as Administrative Agent and Collateral Agent,
and the other Agents party thereto;

WHEREAS, subject to the terms and conditions of the Credit Agreement, Borrower
may obtain New Revolving Loan Commitments and/or New Term Loan Commitments by
entering into one or more Joinder Agreements with the New Term Loan Lenders;

WHEREAS, pursuant to Section 2.25 of the Credit Agreement, the Credit Agreement
may, without the consent of any other Lenders, be amended as may be necessary or
appropriate, in the opinion of the Administrative Agent, to give effect to the
provisions of Section 2.25 of the Credit Agreement; and

WHEREAS, the Borrower may, in its sole discretion, use the proceeds of the
Additional Series A-3 Tranche A Term Loans (as defined below) for any purpose
not prohibited by the Credit Agreement, including repayment of outstanding
Indebtedness of the Borrower.

NOW, THEREFORE, in consideration of the premises and agreements, provisions and
covenants herein contained, the parties hereto agree as follows:

Each New Term Loan Lender (i) confirms that it has received a copy of the Credit
Agreement and the other Credit Documents, together with copies of the financial
statements referred to therein and such other documents and information as it
has deemed appropriate to make its own credit analysis and decision to enter
into this Agreement; (ii) agrees that it will, independently and without
reliance

--------------------------------------------------------------------------------

upon the Administrative Agent or any other Lender or Agent and based on such
documents and information as it shall deem appropriate at the time, continue to
make its own credit decisions in taking or not taking action under the Credit
Agreement; (iii) appoints and authorizes Administrative Agent and each other
Agent to take such action as agent on its behalf and to exercise such powers
under the Credit Agreement and the other Credit Documents as are delegated to
Administrative Agent or such other Agent, as the case may be, by the terms
thereof, together with such powers as are reasonably incidental thereto; and
(iv) agrees that it will perform in accordance with their terms all of the
obligations which by the terms of the Credit Agreement are required to be
performed by it as a Lender.

Each New Term Loan Lender hereby commits to provide its respective New Term Loan
Commitment (each an “Additional Series A-3 Tranche A Term Loan Commitment”) as
set forth on Schedule A annexed hereto, on the terms and subject to the
conditions set forth below:

 

1. Additional Series A-3 Tranche A Term Loan Commitments. The terms and
provisions of the New Term Loans made pursuant to this Agreement (the
“Additional Series A-3 Tranche A Term Loans” and each an “Additional Series A-3
Tranche A Term Loan”) shall be identical to, and constitute, Series A-3 Tranche
A Term Loans for all purposes under the Credit Agreement. The Additional Series
A-3 Tranche A Term Loan Commitments and Additional Series A-3 Tranche A Term
Loans made pursuant thereto shall be subject to the provisions of the Credit
Agreement and the other Credit Documents, and shall constitute “Tranche A Term
Loan Exposure” and “Tranche A Term Loans”, respectively, thereunder.

 

2. Closing Fee. Borrower agrees to pay on the Additional Series A-3 Tranche A
Term Loan Funding Date (as defined below) to Administrative Agent, for the
account of each New Term Loan Lender party to this Agreement, as fee
compensation for the commitment of such New Term Loan Lender’s Additional Series
A-3 Tranche A Loan Commitments, a closing fee in an amount equal to 0.25% of the
aggregate principal amount of such New Term Loan Lender’s allocated Additional
Series A-3 Tranche A Term Loan Commitments which are actually funded on the
Additional Series A-3 Tranche A Term Loan Funding Date.

 

3. Proposed Borrowing. In accordance with Section 2.25 of the Credit Agreement,
Borrower has previously delivered to Administrative Agent an executed Funding
Notice for Additional Series A-3 Tranche A Term Loans, requesting a proposed
borrowing in the principal amount of up to $225,560,593.40 (the “Proposed
Borrowing”) on the date hereof (the “Additional Series A-3 Tranche A Term Loan
Funding Date”). Each New Term Loan Lender shall make its Additional Series A-3
Tranche A Term Loan available to Administrative Agent not later than 11:00 a.m.
(New York City time) on the date hereof, by wire transfer of same day funds in
Dollars at the Principal Office designated by Administrative Agent. Promptly
upon receipt thereof, Administrative Agent shall make the proceeds of the
Additional Series A-3 Tranche A Term Loan available to Borrower on the date
hereof by causing an amount of same day funds in Dollars equal to the proceeds
of all such loans received by Administrative Agent from New Term Loan Lenders to
be credited to the account of Borrower, at the Principal Office designated by
Administrative Agent or to such other account as may be designated in writing to
Administrative Agent by Borrower.

 

4. New Lenders. Each New Term Loan Lender (other than any New Term Loan Lender
that, immediately prior to the execution of this Agreement, is a “Lender” under
the Credit Agreement) acknowledges and agrees that upon its execution of this
Agreement its Additional Series A-3 Tranche A Term Loan Commitments shall be
effective and that such New Term Loan Lender shall become a “Lender” under, and
for all purposes of, the Credit Agreement and the other Credit Documents, and
shall be subject to and bound by the terms thereof, and shall perform all the
obligations of and shall have all rights of a Lender thereunder.

 

-2-

--------------------------------------------------------------------------------

5. Credit Agreement Governs. Additional Series A-3 Tranche A Term Loans shall be
subject to the provisions of the Credit Agreement and the other Credit
Documents, except as set forth in this Agreement, and shall constitute Tranche A
Term Loans thereunder.

 

6. Borrower’s Certifications. By its execution of this Agreement, the
undersigned officer, to the best of his or her knowledge, and Borrower hereby
certify that:

 

  i. The representations and warranties contained in the Credit Agreement and
the other Credit Documents are true and correct in all material respects on and
as of the date hereof to the same extent as though made on and as of the date
hereof, except to the extent such representations and warranties specifically
relate to an earlier date, in which case such representations and warranties
were true and correct in all material respects on and as of such earlier date;

 

  ii. No event has occurred and is continuing or would result from the
consummation of the Proposed Borrowing contemplated hereby that would constitute
a Default or an Event of Default; and

 

  iii. Borrower has performed in all material respects all agreements and
satisfied all conditions which the Credit Agreement provides shall be performed
or satisfied by it on or before the date hereof in connection with the Proposed
Borrowing.

 

7. Borrower Covenants. By its execution of this Agreement, Borrower hereby
covenants that:

 

  i. Borrower shall deliver or cause to be delivered, on or before the
Additional Series A-3 Tranche A Term Loan Funding Date, the following legal
opinions and documents: originally executed copies of the favorable written
opinions of (a) Skadden, Arps, Slate, Meagher & Flom LLP, U.S. counsel to the
Credit Parties, (b) Chancery Chambers, special Barbados counsel to the Credit
Parties, (c) Norton Rose Fulbright Canada LLP, special Canadian counsel to the
Credit Parties, (d) Baker & McKenzie, special Luxembourg counsel to the Credit
Parties, (e) Conyers Dill & Pearman Limited, special Bermuda counsel to the
Credit Parties, (f) Arthur Cox, special Ireland counsel to the Credit Parties,
(g) Baker & McKenzie, special Switzerland counsel to the Credit Parties,
(h) Venable LLP, special Maryland counsel to the Credit Parties, (i) Souza,
Cescon, Barrieu & Flesch Advogados, special Brazil counsel to the Credit
Parties, (j) Squire Sanders Święcicki Krześniak sp.k., special Poland counsel to
the Credit Parties and (k) Tark Grunte Sutkiene, special Lithuania counsel to
the Credit Parties, together with all other legal opinions and other documents
reasonably requested by Administrative Agent in connection with this Agreement.

 

8. Eligible Assignee. By its execution of this Agreement, each New Term Loan
Lender (other than any New Term Loan Lender that, immediately prior to the
execution of this Agreement, is a “Lender” under the Credit Agreement)
represents and warrants that it is an Eligible Assignee.

 

9. Notice. For purposes of the Credit Agreement, the initial notice address of
each New Term Loan Lender shall be as set forth below its signature below.

 

10. Non-U.S. Lenders. For each New Term Loan Lender that is a Non-U.S. Lender,
delivered herewith to Administrative Agent are such forms, certificates or other
evidence with respect to United States federal income tax withholding matters as
such New Term Loan Lender may be required to deliver to Administrative Agent
pursuant to subsection 2.20(d) of the Credit Agreement.

 

-3-

--------------------------------------------------------------------------------

11. Recordation of the New Loans. Upon execution and delivery hereof,
Administrative Agent will record in the Register the Additional Series A-3
Tranche A Term Loans made by New Term Loan Lenders pursuant hereto as being of
the same Class as the Series A-3 Tranche A Term Loans.

 

12. Reaffirmation.

 

  i. Each Credit Party hereby expressly acknowledges the terms of this Agreement
and reaffirms, as of the date hereof, the covenants and agreements contained in
each Credit Document to which it is a party, including, in each case, such
covenants and agreements as in effect immediately after giving effect to this
Agreement and the transactions contemplated hereby.

 

  ii. Each Credit Party, by its signature below, hereby affirms and confirms
(a) its obligations under each of the Credit Documents to which it is a party,
and (b) the pledge of and/or grant of a security interest or hypothec in its
assets as Collateral to secure such Obligations, all as provided in the
Collateral Documents as originally executed, and acknowledges and agrees that
such guarantee, pledge and/or grant continue in full force and effect in respect
of, and to secure, such Obligations under the Credit Agreement and the other
Credit Documents.

 

  iii. Each Credit Party acknowledges and agrees that each of the Credit
Documents in existence as of the date hereof shall be henceforth read and
construed in accordance with and so as to give full force and effect to the
ratifications, confirmations, acknowledgements and agreements made herein.

 

13. Amendment, Modification and Waiver. This Agreement may not be amended,
modified or waived except by an instrument or instruments in writing signed and
delivered on behalf of each of the parties hereto.

 

14. Entire Agreement. This Agreement, the Credit Agreement, the other Credit
Documents and the letter agreement dated as of February 4, 2014 between the New
Term Loan Lenders, the Borrower and GSLP as Administrative Agent and Collateral
Agent constitute the entire agreement among the parties with respect to the
subject matter hereof and thereof and supersede all other prior agreements and
understandings, both written and verbal, among the parties or any of them with
respect to the subject matter hereof. It is understood and agreed that each
reference in each Credit Document to the Credit Agreement, whether direct or
indirect, shall hereafter be deemed to be a reference to the Credit Agreement as
amended and supplemented hereby and that this Agreement is a Credit Document.

 

15. GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES
HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

 

16. Severability. Any term or provision of this Agreement which is invalid or
unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective
to the extent of such invalidity or unenforceability without rendering invalid
or unenforceable the remaining terms and provisions of this Agreement or
affecting the validity or enforceability of any of the terms or provisions of
this Agreement in any other jurisdiction. If any provision of this Agreement is
so broad as to be unenforceable, the provision shall be interpreted to be only
so broad as would be enforceable.

 

-4-

--------------------------------------------------------------------------------

17. Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed to be an original, but all of which shall constitute one and the
same agreement.

[Remainder of page intentionally left blank]

 

-5-

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized
officer to execute and deliver this Agreement as of the date first written
above.

 

BARCLAYS BANK PLC as a “New Term Loan Lender” By:  

/s/ Naom Azachi

Name:   Naom Azachi Title:   Vice President

Notice Address: 745 7th Avenue New York, NY 10019

Attention:   Mathew Cybul Telephone:   212-526-5851 Facsimile:   212-526-5115

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

CITIBANK, N.A., as a “New Term Loan Lender” By:  

/s/ Laura Fogarty

Name:   Laura Fogarty Title:   Vice President

Notice Address: 388 Greenwich Street, Floor 32 New York, NY 10013 Attention:  
Laura Fogarty Telephone:   (212) 816-2197 Facsimile:   (646) 862-8137

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

MORGAN STANLEY SENIOR FUNDING INC., as a “New Term Loan Lender” By:  

/s/ Alice Lee

Name:   Alice Lee Title:   Authorized Signatory Notice Address: Morgan Stanley
Loan Servicing 1300 Thames Street Wharf, 4th Floor Baltimore, MD 21231
443-627-4355 718-233-2140 msloanservicing@morganstanley.com

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

SUNTRUST BANK, as a “New Term Loan Lender” By:  

/s/ Katherine Bass

Name:   Katherine Bass Title:   Director Notice Address: 3333 Peachtree Road, NE
7th Floor Atlanta, GA 30326 Attention: Katherine Bass Telephone: 404-439-7602
Facsimile: 404-439-7600

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

DBS BANK LTD., LOS ANGELES AGENCY, as a “New Term Loan Lender” By:  

/s/ James McWalters

Name:   James McWalters Title:   General Manager

Notice Address: 725 South Figueroa Street Suite 2000 Los Angeles, CA 90017
Attention:   General Manager Telephone:   213-627-0222 Facsimile:   213-627-0228

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized
officer to execute and deliver this Amendment No. 8 as of the date first written
above.

 

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. as Borrower By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Senior Vice President and Treasurer VALEANT
PHARMACEUTICALS INTERNATIONAL as Guarantor By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer BAUSCH & LOMB INCORPORATED as Guarantor By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer BAUSCH & LOMB HOLDINGS INCORPORATED as Guarantor By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

ATON PHARMA, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer

CORIA LABORATORIES, LTD.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer

DOW PHARMACEUTICAL SCIENCES, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer

OBAGI MEDICAL PRODUCTS, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

OMP, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

MEDICIS PHARMACEUTICAL CORPORATION

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President, Chief    
Financial Officer and Treasurer

DR. LEWINN’S PRIVATE FORMULA INTERNATIONAL, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

OCEANSIDE PHARMACEUTICALS, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

PRINCETON PHARMA HOLDINGS, LLC

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

PRIVATE FORMULA CORP. as Guarantor By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

RENAUD SKIN CARE LABORATORIES, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer
VALEANT BIOMEDICALS, INC. as Guarantor By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

VALEANT PHARMACEUTICALS NORTH AMERICA LLC

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President and Chief    
Financial Officer

BIOVAIL AMERICAS CORP.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

ORAPHARMA, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President, Chief    
Financial Officer and Treasurer

ORAPHARMA TOPCO HOLDINGS, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Executive Vice President, Chief    
Financial Officer and Treasurer

PRESTWICK PHARMACEUTICALS, INC.

as Guarantor

By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:   Chief Financial Officer and Treasurer

IOLAB CORPORATION

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

TECHNOLAS PERFECT VISION, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

BAUSCH & LOMB PHARMA HOLDINGS CORP.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

BAUSCH & LOMB CHINA, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

BAUSCH & LOMB SOUTH ASIA, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

BAUSCH & LOMB TECHNOLOGY CORPORATION

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

RHC HOLDINGS, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Treasurer

SIGHT SAVERS, INC.

as Guarantor

By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

BAUSCH & LOMB INTERNATIONAL INC. as Guarantor By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer BAUSCH & LOMB
REALTY CORPORATION as Guarantor By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

ISTA PHARMACEUTICALS, LLC as Guarantor By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Vice President and Treasurer VRX HOLDCO INC.
as Guarantor By:  

/s/ Linda LaGorga

  Name:   Linda LaGorga   Title:   Chief Financial Officer and Treasurer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

VALEANT INTERNATIONAL BERMUDA as Guarantor By:  

/s/ Peter J. McCurdy

  Name:   Peter J. McCurdy   Title:   President and Assistant Secretary VALEANT
PHARMACEUTICALS NOMINEE BERMUDA as Guarantor By:  

/s/ Peter J. McCurdy

  Name:   Peter J. McCurdy   Title:   President and Assistant Secretary

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

HYTHE PROPERTY INCORPORATED as Guarantor By:  

/s/ Mauricio Zavala

  Name:   Mauricio Zavala   Title:   Assistant Secretary

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

VALEANT CANADA GP LIMITED as Guarantor By:  

/s/ Robert R. Chai-Onn

  Name:   Robert R. Chai-Onn   Title:   Executive Vice President and General
Counsel

VALEANT CANADA LP by its sole general partner, VALEANT CANADA GP LIMITED

as Guarantor

By:  

/s/ Robert R. Chai-Onn

  Name:   Robert R. Chai-Onn   Title:   Executive Vice President and General
Counsel V-BAC HOLDING CORP. as Guarantor By:  

/s/ Robert R. Chai-Onn

Name:   Robert R. Chai-Onn   Title:   Vice President

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

VALEANT PHARMACEUTICALS IRELAND as Guarantor By:  

/s/ Graham Jackson

  Name:   Graham Jackson   Title:   Director

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

BIOVAIL INTERNATIONAL S.À R.L. as Guarantor By:  

/s/ Kuy Ly Ang

  Name:   Kuy Ly Ang   Title:   Manager VALEANT PHARMACEUTICALS LUXEMBOURG S.À
R.L. as Guarantor By:  

/s/ Kuy Ly Ang

  Name:   Kuy Ly Ang   Title:   Manager

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

PHARMASWISS SA as Guarantor By:  

/s/ Matthias Courvoisier

  Name:   Matthias Courvoisier   Title:   Director

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     Valeant Holdco 2 Pty Ltd (ACN 154 341 367)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print) Signed by  
  Wirra Holdings Pty Limited (ACN 122 216 577)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     Wirra Operations Pty Limited (ACN 122 250 088)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print) Signed by  
  iNova Pharmaceuticals (Australia) Pty Limited (ACN 000 222 408)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print) Signed by  
  Wirra IP Pty Limited (ACN 122 536 350)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     iNova Sub Pty Limited (ACN 134 398 815)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by two directors:

   

/s/ Robert R. Chai-Onn

   

Howard B. Schiller

Signature of director     Signature of director

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     Valeant Pharmaceuticals Australasia Pty Limited (ACN 001 083 352)
   

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by a director and
secretary/director:

   

/s/ Robert R. Chai-Onn

   

/s/ Linda A. LaGorga

Signature of director     Signature of director/secretary

Robert R. Chai-Onn

   

Linda A. LaGorga

Name of director (please print)     Name of director/secretary (please print)
Signed by     DermaTech Pty Limited (ACN 003 982 161)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by a director and
secretary/director:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director/secretary

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director/secretary (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     Private Formula International Holdings Pty Ltd (ACN 095 450 918)  
 

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by a director and
secretary/director:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director/secretary

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director/secretary (please print)
Signed by     Private Formula International Pty Ltd (ACN 095 451 442)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by a director and
secretary/director:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director/secretary

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director/secretary (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Signed by     Ganehill Pty Ltd (ACN 065 261 538)    

as Guarantor

in accordance with section 127 of the Corporations Act 2001 by a director and
secretary/director:

   

/s/ Robert R. Chai-Onn

   

/s/ Howard B. Schiller

Signature of director     Signature of director/secretary

Robert R. Chai-Onn

   

Howard B. Schiller

Name of director (please print)     Name of director/secretary (please print)

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

UCYCLYD PHARMA, INC. as Guarantor By:  

/s/ Howard B. Schiller

  Name:   Howard B. Schiller   Title:  

Executive Vice President, Chief

Financial Officer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

VALEANT EUROPE B.V. as Guarantor By:  

/s/ Rob Meijer

  Name:   Rob Meijer   Title:   Managing Director A

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

PRZEDSIEBIORSTWO FARMACEUTYCZNE

JELFA S.A.

as Guarantor By:  

/s/ Marcin Wnukowski

  Name:   Marcin Wnukowski   Title:   Attorney-In-Fact VALEANT SP. ZOO as
Guarantor By:  

/s/ Marcin Wnukowski

  Name:   Marcin Wnukowski   Title:   Attorney-In-Fact

VP VALEANT SP. Z.O.O.SP.J.

as Guarantor

By:  

/s/ Marcin Wnukowski

  Name:   Marcin Wnukowski   Title:   Attorney-In-Fact

VALEANT SPOLKA Z ORGANICZONA

ODPOWIEDZIALNOSCIA SP.J.

as Guarantor By:  

/s/ Marcin Wnukowski

  Name:   Marcin Wnukowski   Title:   Attorney-In-Fact

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

LABENNE PARTICIPACOES LTDA as Guarantor By:  

/s/ Marcelo Noll Barboza

  Name:   Marcelo Noll Barboza   Title:   Officer By:  

/s/ Mauricio Santos da Luz

  Name:   Mauricio Santos da Luz   Title:   Officer PROBIOTICA LABORATORIES
LTDA. as Guarantor By:  

/s/ Marcelo Noll Barboza

  Name:   Marcelo Noll Barboza   Title:   Officer By:  

/s/ Mauricio Santos da Luz

  Name:   Mauricio Santos da Luz   Title:   Officer

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

AB SANITAS as Guarantor By:  

/s/ Saulius Žemaitis

  Name:   Saulius Žemaitis   Title:   General Manager

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

Consented to by: GOLDMAN SACHS LENDING PARTNERS LLC As Administrative Agent and
Collateral Agent By:  

/s/ Elizabeth Fischer

  Authorized Signatory

 

[Signature Page to Joinder Agreement]

--------------------------------------------------------------------------------

SCHEDULE A

TO JOINDER AGREEMENT

 

Name of Lender

  

Type of Commitment

   Amount  

BARCLAYS BANK PLC

   Additional Series A-3 Tranche A Term Loan Commitment    $ 74,952,387.64   

CITIBANK, N.A.

   Additional Series A-3 Tranche A Term Loan Commitment    $ 75,000,000.00   

MORGAN STANLEY SENIOR FUNDING, INC.

   Additional Series A-3 Tranche A Term Loan Commitment    $ 20,770,632.32   

SUNTRUST BANK

   Additional Series A-3 Tranche A Term Loan Commitment    $ 36,837,573.44   

DBS BANK LTD., LOS ANGELES AGENCY

   Additional Series A-3 Tranche A Term Loan Commitment    $ 18,000,000.00      
  

 

 

        Total: $ 225,560,593.40